Clinical Trial Update: Safety of Intravenous Apramycin in Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety study of intravenous apramycin in adults has completed, with results posted in December 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• apramycin (apramycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Infection | Phase 1 | Status: COMPLETED | Results posted: 2024-12-10